Aldeyra Therapeutics, Inc. business relationships
Companies named in Aldeyra Therapeutics, Inc.’s 10-K filed 2026-02-27, and public companies whose annual reports name Aldeyra Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- 4 / 100 Top 3% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Aldeyra Therapeutics, Inc.’s annual report 2
“We currently plan to commercialize reproxalap through a collaboration with AbbVie, should AbbVie choose to exercise the AbbVie Option.” SEC filing
“Although the AbbVie Option Agreement was not considered to be a vendor-customer relationship, the Company used ASC 606 to conclude that the $ 6.0 million liability would be considered the transaction price (the Transaction Price) and all other amounts due to the Company under the Collaboration Agree...” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.